RAPT Therapeutics (RAPT) Other Gross PP&E Adjustments: 2020-2024
Historic Other Gross PP&E Adjustments for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $7.4 million.
- Therapeutics' Other Gross PP&E Adjustments rose 32.76% to $7.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $21.2 million, marking a year-over-year increase of 37.09%. This contributed to the annual value of $349,000 for FY2023, which is 1617.39% up from last year.
- Latest data reveals that Therapeutics reported Other Gross PP&E Adjustments of $7.4 million as of Q3 2024, which was up 7.66% from $6.9 million recorded in Q2 2024.
- Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $10.0 million during Q1 2021, with a 5-year trough of -$23,000 in Q4 2022.
- For the 3-year period, Therapeutics' Other Gross PP&E Adjustments averaged around $4.5 million, with its median value being $4.8 million (2023).
- In the last 5 years, Therapeutics' Other Gross PP&E Adjustments slumped by 100.28% in 2022 and then skyrocketed by 1,617.39% in 2023.
- Quarterly analysis of 5 years shows Therapeutics' Other Gross PP&E Adjustments stood at $8.8 million in 2020, then fell by 7.93% to $8.1 million in 2021, then tumbled by 100.28% to -$23,000 in 2022, then soared by 1,617.39% to $349,000 in 2023, then surged by 32.76% to $7.4 million in 2024.
- Its Other Gross PP&E Adjustments stands at $7.4 million for Q3 2024, versus $6.9 million for Q2 2024 and $6.6 million for Q1 2024.